
Procaps Group S.A.
PROCNASDAQHealthcare
$1.01
+$1.01(+100.00%)
Market Cap$102083710
P/E Ratio—
52W High$3.775
52W Low$0.5
Procaps Group S.A.(PROC)股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · PROC · 截至 Jun 9, 2026
关键指标
探索 Procaps Group S.A. 数据
proc stock data · financials竞争对手与同行
proc competitors#TickerCompanyPriceChangeMkt Cap
#1Procaps Group S.A.
$1.01+100.00%$102.1M#2Augmedix, Inc.
$2.35-0.21%$115.9M#3Genetic Technologies Limited
$0.77+0.00%$3.7M#4Graybug Vision, Inc.
$5.50-10.80%$121.0M#5Opiant Pharmaceuticals, Inc.
$20.65+0.00%$108.8M#6OptiNose, Inc.
$9.60+0.00%$97.2M关于 Procaps Group S.A.
Procaps Group S.A. established in Luxembourg in 1977, functions as a global pharmaceutical enterprise dedicated to the creation, production, and distribution of a broad spectrum of pharmaceutical sol…
what is procaps group s.a. · proc stock overview · procaps group s.a. company profile · who is procaps group s.a. ceo · proc NASDAQ · procaps group s.a. headquarters · procaps group s.a. business segments
关于股票概览与关键数据
Procaps Group S.A.(PROC)是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司,于 Dec 9, 2019 在 NASDAQ 上市。截至最近交易日,PROC 股价为 $1.01,市值约为 $102.1M。过去12个月累计回报 —,年初至今回报 —。
常见问题
截至最近一个交易日,Procaps Group S.A.(PROC)股价为 $1.01,在 NASDAQ 上市,52周区间为 $0.50 – $3.77。
PROC 最新股价PROC quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议